A single gene-editing treatment could someday protect against heart disease, high cholesterol, and other common conditions ...
Specific Biologics, a biotechnology company developing precision gene-editing therapies, has completed an oversubscribed $35 ...
Rice University's Han Xiao has used his AI-supported Sequence Display technology to expand the targeting abilities of ...
Google DeepMind’s Demis Hassabis and John Jumper won half of the 2024 chemistry Nobel for AlphaFold, which predicts the ...
We look at some of the key biotech developments, companies, and clinical data to watch at AHA Scientific Sessions 2026.
The plan builds on recent FDA moves to speed "personalized" treatments by offering an approval framework for therapies ...
A systematic review of 21 studies finds CRISPR/Cas9 therapies for beta-thalassemia and sickle cell disease achieve high ...
Scientists can now edit genes in precise locations deep in the brain and body without the use of invasive surgery or implants ...
For years, gene editing in food and agriculture was largely a conversation about what might someday be possible.
Global market projected to expand from USD 8.94 billion in 2025 to USD 10.44 billion in 2026, registering an 18.1% CAGR ...
Liver biopsy confirmed base editing corrected a disease-causing SERPINA1 mutation in a living human liver, offering stronger ...
Ohio's six-month freeze on new Medicaid home care and hospice providers is set to expire Nov. 14, raising concerns among disabled residents who face gaps when aides leave. South Dakota Voters Weigh ...